Recent increases in infections caused by Mycobacterium tuberculosis and nontuberculous mycobacteria are a serious hazard to public health (2, 6, (11) (12) (13) 20) . More than 30 mycobacterial species are recognized as pathogenic or potentially pathogenic. Mixed infections with two or more species (1, 18, 29, 31) and nosocomial infections (3, 8, 19, 25, 27) are always troublesome. Therefore, timely identification of causative mycobacteria is imperative for appropriate therapy and epidemiological analyses.
Genotyping the sequence polymorphisms in the genus Mycobacterium can identify species quickly and unequivocally. PCR-restriction fragment polymorphism analysis (PRA) of the hsp65 gene (4, 21, 22, 28) , 16S ribosomal DNA (rDNA) (5, 14, 15, 30) , 16S-23S rDNA internal transcribed spacer (ITS) (23) , dnaJ (26) , rpoB (17) , and gyrB (16) has been intensively studied. However, these methods are not applicable for a polymycobacterial sample because too many restriction fragments from multiple species of mycobacteria in it blur the analysis.
We developed a fluorescence capillary electrophoresis (FCE)-based restriction fragment-single-strand conformation polymorphism (FCE-RF-SSCP) technique which can simultaneously identify multiple mycobacterial species in a sample. We first established an algorithm for species identification by applying this technique to 110 defined mycobacterial strains.
The technique was further validated on "spiked" specimens, clinical sputum specimens, and sputum obtained from a patient with mixed M. avium and M. intracellulare infection.
(This work was presented in part at the 102nd Annual Meeting of the American Society for Microbiology, Salt Lake City, Utah, 20 May 2002.)
MATERIALS AND METHODS
Mycobacteria and DNA preparation. Genomic DNAs used for the establishment of an algorithm were isolated from 37 reference strains and 73 clinical isolates representing 19 mycobacterial species and M. tuberculosis complex with Isoplant (Nippon Gene, Toyama, Japan) according to the manufacturer's instructions (Table 1) . Clinical isolates were identified by conventional biochemical tests, Accu-Probe (Gen-Probe, Inc., San Diego, Calif.), DDH Mycobacteria 'Kyokuto' (Kyokuto Pharmaceutical Ind. Co., Ltd., Tokyo, Japan), or partial 16S rDNA sequencing.
Clinical sputum specimens. Fifty-one sputum specimens from patients with suspected M. tuberculosis or nontuberculous mycobacterial infections were obtained from Kobe City General Hospital. After decontamination with N-acetyl-L-cystein-NaOH, DNA was extracted from these specimens with a respiratory specimen preparation kit (Roche Diagnostics GmbH). The sputum specimens were also subjected to acid-fast staining and cultured. One frozen sputum sample obtained from a patient with mixed M. avium and M. intracellulare infection was retrospectively analyzed by FCE-RF-SSCP.
DNA amplification and restriction enzyme digestion. Genus Mycobacteriumspecific primers Sp1f and Sp2r, designed by Roth et al. (23) , were used to amplify part of the 16S-23S rRNA gene spacer. A reaction mixture (50 l) containing 20 pmol of 6-carboxyfluorescein (FAM)-labeled Sp1f and 5-hexachlorofluorescein (HEX)-tagged Sp2r primers, 1.5 mM MgCl 2 , 3.5 l of dimethyl sulfoxide, and 1 to 20 l of DNA solution was amplified with the Expand high-fidelity PCR system (Roche Diagnostics GmbH) following the thermal profile method of Roth et al. (23) . Fivefold-diluted PCR product (9 l) was digested at 37°C for 3 h (24) . Five nanograms of purified genomic DNAs from each species was suspended together in the PCR mixture and used for FCE-RF-SSCP analysis after the PCR. 6-carboxy-X-rhodamine-labeled internal standard, FAM-labeled fragments, and HEX-labeled fragments are shown as red peaks, blue peaks, and green peaks, respectively. Arbitrary electrophoretic mobility values for internal standard were assigned as follows: peak 1, 3859; peak 2, 3960; peak 3, 4096; peak 4, 4125; peak 5, 4157; peak 6, 4219; peak 7, 4404; peak 8, 4426; peak 9, 4462; peak 10, 4493; peak 11, 4817; peak 12, 4880; peak 13, 4919; peak 14, 5150; peak 15, 5188; peak 16, 5454; peak 17, 5485; peak 18, 5538; peak 19, 5563; peak 20, 5675; peak 21, 5702; peak 22, 5716; and peak 23, 5739. 7H9 broth until the turbidity equaled a McFarland no. 1 standard and was then adjusted to the same cell density with an appropriate dilution. Each of these liquid cultures (10 l) was mixed with 100 l of acid-fast bacillus-negative sputum sample that was diluted with an equivalent amount of phosphate-buffered saline. The amount of M. tuberculosis H37Rv was serially diluted twofold, while the other strains were kept constant to produce five levels: no dilution, twofold, fourfold, eightfold, and 16-fold dilutions. One hundred microliters of each mixture was used for DNA extraction after NALC-NaOH treatment. SSCP electrophoresis. The PCR products were analyzed for SSCP on an ABI Prism 310 Genetic Analyzer (Applied Biosystems, Foster City, Calif.) by Gillman's method (7) with modifications: 0.5 l of 0.3 N NaOH was added to the SSCP analysis master mix, the SSCP analysis mixture was then denatured by heating at 95°C for 5 min and left at room temperature, and the retention times of the fluorescently labeled fragments were determined against that of the 6-carboxy-X-rhodamine-labeled internal standard (Fig. 1) . In addition, the conditions for electrophoresis were set as follows: 5-s injection time, 15.0-kV injection voltage, 13-kV electrophoresis voltage, 210-s syringe pump time, 30°C constant temperature of the capillary at a room temperature of 23 to 24°C, and a 23-min collection time. The PCR products and corresponding HaeIII restriction fragments were run in two separate sample tubes after appropriate dilution with sterilized water (in most cases, diluted 1:10).
RESULTS
FCE-RF-SSCP analysis of 19 mycobacterial species and M. tuberculosis complex showed 23 SSCP patterns that could be used as the algorithm to identify the species and subtypes of these mycobacteria ( Table 2 ). The method is highly reproducible, with reasonable intraspecies stability of SSCP (Table 2) . Based on the standard deviation of SSCP peak placement, we applied a tolerance level of Ϯ5 data points in the algorithm for species identification. The established polymorphisms among SSCP patterns for the 19 species and M. tuberculosis complex suggest that species can be distinguished even when multiple mycobacterial species are found in a single sample. To test this hypothesis, two model mycobacterial communities representing a mixture of rapidand slow-growing species (model A) and the most ubiquitous mycobacterial species found in clinical practice (model B) were constructed. The FCE-RF-SSCP analysis of the model communities yielded characteristics SSCP patterns (Fig. 2 ) from which all of the mixed strains were correctly identified ( Table 3) .
The species belonging to each peak in Fig. 2 were identified as follows (Table 3 ). In the initial step, we listed all of the possible species under the peaks with the algorithm, then the species that appeared on all four peaks, undigested 6-FAM, undigested HEX, HaeIII 6-FAM, and HaeIII HEX, were judged as the existing species in a sample. The blue peak (3690.0 data points) and green peak (3886.1 data points) in the HaeIII fragments of model B are considered overlapping peaks originating from M. avium and M. intracellulare I. Besides these two model communities, our study of various combinations of three to five species demonstrated that this technique would work clinically (data not shown).
When sputum samples spiked with M. avium, M. intracellulare, and different amounts of M. tuberculosis H37Rv cells were analyzed, the peaks of single-stranded DNA from M. tuberculosis H37Rv were discernible in fourfold-but not in eightfolddiluted samples (Fig. 3) . No unexpected peaks or interference from the spiked samples were observed. These results indicate that the detection limit for each mycobacterium is up to 25% of the amount relative to the other two species.
Fifty-one sputum specimens from patients with suspected M. tuberculosis or nontuberculous mycobacterial infections were tested by FCE-RF-SSCP and the Amplicor assay (Table 4) . These specimens were also subjected to acid-fast staining and cultured. Species identified by FCE-RF-SSCP, Amplicor, and the culture method were always the same. In addition to the three species targeted by Amplicor, FCE-RF-SSCP could identify M. abscessus and M. kansasii. Two specimens were negative by smear and culture tests but showed positive results only in the Amplicor (specimens 32 and 33); this may be due to the higher sensitivity of Amplicor than FCE-RF-SSCP or may represent false-positive results of the Amplicor test. The 51 sputum specimens were not amplified nonspecifically. The results also support the specificity of the primer set used in this study and warrant the application of our technique to the direct identification of mycobacterial species in a sputum specimen.
FCE-RF-SSCP of sputum obtained from a patient with mixed M. avium and M. intracellulare infection gave SSCP patterns corresponding to these two species (4421.3 data points of blue and 4480.0 of green for M. avium, and 4442.0 blue and 4515.9 green for M. intracellulare I). The blue peak (3687.0) and green peak (3886.2) in HaeIII are the overlapping peaks originating from these species (Fig. 4) . This result demonstrates the effectiveness of FCE-RF-SSCP analysis in the direct identification of mixed infections from patient specimens.
DISCUSSION
We developed a simple algorithm using FCE-RF-SSCP with genus Mycobacterium-specific primers (23) to simultaneously distinguish multiple mycobacterial species in a polymicrobial sample. This is the first report to expand the PRA method to this application. Compared with ordinary PRA methods, this technique is unique because it analyzes only terminal restriction fragments and undigested fragments. In this method, the troublesome gel-to-gel inconsistencies seen in agarose-based methods are avoided, as FCE gives high resolution and reproducible analyses by with an internal standard in each sample. Recently, Gillman et al. (7) used FCE for the identification of mycobacterial species by using four pairs of fluorescent primers of the 16S rRNA gene and subsequently analyzed the SSCPs. Without using a restriction enzyme, they obtained spe- (17) used PRA of rpoB DNA for direct identification of mycobacterial species in sputum samples and bronchoalveolar lavage specimens. Although this method showed improved identification of clinical specimens, application is limited to a single mycobacterial infection because too many fragments from a mixed infection blur the analysis. In our method, peaks from four types of fragments were obtained individually and used to identify each species. Since the number of SSCP peaks originating from each primer for a single species is theoretically one, multiple mycobacterial species in a sample can be identified with the algorithm. Multiple peaks obtained from M. terrae and M. nonchronogenicum are due to different stable conformations of the same fragment (7, 10) or the existence of multicopies of ITS in these species.
The newly developed technique, FCE-RF-SSCP, was validated on artificially constructed mycobacterial communities, clinical sputum specimens, and a sputum specimen from a patient with mixed M. avium and M. intracellulare infection. All results supported the ability of the technique to directly identify multiple mycobacterial species present in one specimen. Further investigations would accumulate more SSCP patterns from more Mycobacterium species and perform a multicenter study to ensure applicability in a laboratory setting.
